CA51164-1A - 0x0000000000007470

Healthy Males & Females

Lark

* Stipend may pay up to reflected amount.
Start Date: 
December 3, 2026 - 2:45pm
End Date: 
January 2, 2027 - 10:00am

Study Details

Study Number: CA51164
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,250.00

Study Criteria

Age: 19 - 55
BMI: 27 - 39.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to lower glucose and aid weight loss.
Route of Administration: Injection subcutaneous

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Friday 11/20/2026
Tuesday 11/24/2026
Monday 11/30/2026
Wednesday 12/2/2026

Doctor Exam Dates:

Event Day Event Date
Friday 11/20/2026
Tuesday 11/24/2026
Monday 11/30/2026
Wednesday 12/2/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 12/3/2026 2:45:00 PM Monday 12/7/2026 9:45:00 AM 1 Lincoln
Return Friday 12/11/2026 8:15:00 AM Friday 12/11/2026 9:45:00 AM 1 Lincoln
Return Monday 12/14/2026 8:15:00 AM Monday 12/14/2026 9:15:00 AM 1 Lincoln
Return Friday 12/18/2026 8:15:00 AM Friday 12/18/2026 9:15:00 AM 1 Lincoln
Return Wednesday 12/23/2026 8:15:00 AM Wednesday 12/23/2026 9:15:00 AM 1 Lincoln
Return Saturday 1/2/2027 8:15:00 AM Saturday 1/2/2027 10:00:00 AM 1 Lincoln